Genesis Healthcare, Inc.
GENN
$0.0002
$0.000.00%
| 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | 12/31/2019 | |
|---|---|---|---|---|---|
| Revenue | 919.06M | 938.65M | 956.26M | 1.09B | 1.14B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 919.06M | 938.65M | 956.26M | 1.09B | 1.14B |
| Cost of Revenue | 523.71M | 535.01M | 616.94M | 580.53M | 595.95M |
| Gross Profit | 395.35M | 403.64M | 339.32M | 511.72M | 539.49M |
| SG&A Expenses | 148.48M | 144.81M | 149.43M | 151.80M | 147.36M |
| Depreciation & Amortization | 23.66M | 24.37M | 33.82M | 25.99M | 21.76M |
| Other Operating Expenses | 290.85M | 296.27M | 304.01M | 326.32M | 348.83M |
| Total Operating Expenses | 986.70M | 1.00B | 1.10B | 1.08B | 1.11B |
| Operating Income | -67.64M | -61.81M | -147.94M | 7.61M | 21.54M |
| Income Before Tax | -19.35M | -95.75M | -29.77M | 37.90M | -14.93M |
| Income Tax Expenses | -2.55M | 176.00K | -457.00K | -779.00K | 2.43M |
| Earnings from Continuing Operations | -16.80M | -95.93M | -29.32M | 38.68M | -17.36M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 9.13M | 33.14M | 7.31M | -5.17M | 5.96M |
| Net Income | -7.67M | -62.79M | -22.01M | 33.51M | -11.40M |
| EBIT | -67.64M | -61.81M | -147.94M | 7.61M | 21.54M |
| EBITDA | -43.98M | -37.44M | -114.12M | 33.60M | 43.30M |
| EPS Basic | -0.07 | -0.56 | -0.20 | 0.31 | -0.10 |
| Normalized Basic EPS | -0.52 | -0.16 | -0.92 | -0.20 | -0.03 |
| EPS Diluted | -0.07 | -0.56 | -0.20 | 0.24 | -0.16 |
| Normalized Diluted EPS | -0.52 | -0.16 | -0.92 | -0.13 | -0.03 |
| Average Basic Shares Outstanding | 113.29M | 113.15M | 111.23M | 109.72M | 109.38M |
| Average Diluted Shares Outstanding | 113.29M | 113.15M | 111.23M | 167.41M | 109.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
